Samuel C. Blackman, Chief Medical Officer at Day One Biopharmaceuticals, Inc. (DAWN), sold 10,000 shares at $22.75 ($229K) on 2023-01-10, disclosed to the SEC on 2023-01-11.
Open-market sale of $229k DAWN by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.75 | 7,500 | $171K | 74.6% |
| 2 | $23.20 | 2,500 | $58K | 25.4% |
| Total | $22.86 avg | 10,000 | $229K | 100% |
| Filing → |
| DAWN | SELL | 2024-11-12 | $751K | — | Filing → |
| DAWN | SELL | 2024-11-08 | $361K | — | Filing → |
| DAWN | SELL | 2024-11-04 | $8K | — | Filing → |